There is the good news of coronavirus vaccine trials to be conducted in India. Pharma major Dr. Reddy’s Laboratories and Russia’s sovereign wealth fund RDIF have received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in the country.

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India

russias-sovereign-wealth-fund

Russia’s Sovereign Wealth Fund, News on Russia’s Sovereign Wealth Fund, stories on Russia’s Sovereign Wealth Fund, articles on Russia’s Sovereign Wealth Fund, Russia’s Sovereign Wealth Fund stories at Wion, Russia’s Sovereign Wealth Fund news, Russia’s Sovereign Wealth Fund latest news

russias sovereign-wealth-fund

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India